Skip to main content

Table 1 Characteristics of the six patients with rheumatoid arthritis and sinus aspergilloma

From: Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapy

Case

RA durationa (years)

Age at aspergilloma onset (years)

Co-morbidities

Previous RA treatment other than TNFα antagonists

TNFα antagonist, date

Surgery for RA

1

17

53

Hepatitis, hypertension, hypothyroidism, gastric ulcer, bronchiectasis

Glucocorticoid therapy, methotrexate, leflunomide

Infliximab, March 2003

No

2

32

66

Hypertension, tuberculosis, osteoporosis, uveitis, coronary artery disease

Glucocorticoid therapy, methotrexate

Infliximab, November 2001

Yes

3

15

47

Primary tuberculosis, iron-deficiency anemia

Glucocorticoid therapy, methotrexate, leflunomide, salazopyrine

Etanercept, February 2003

Yes

4

39

70

Hypertension

Glucocorticoid therapy, methotrexate

Infliximab, March 2002; etanercept, July 2003

No

5

15

53

--

Glucocorticoid therapy, methotrexate, salazopyrine, hydroxychloroquine

--

Yes

6

12

52

Chronic hepatitis B, iron-deficiency anemia, osteopenia

Glucocorticoid therapy, methotrexate, salazopyrine

--

Yes

  1. aRheumatoid arthritis (RA) duration at aspergilloma diagnosis.